RAD17_HUMAN - dbPTM
RAD17_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RAD17_HUMAN
UniProt AC O75943
Protein Name Cell cycle checkpoint protein RAD17
Gene Name RAD17
Organism Homo sapiens (Human).
Sequence Length 681
Subcellular Localization Nucleus . Phosphorylated form redistributes to discrete nuclear foci upon DNA damage.
Protein Description Essential for sustained cell growth, maintenance of chromosomal stability, and ATR-dependent checkpoint activation upon DNA damage. Has a weak ATPase activity required for binding to chromatin. Participates in the recruitment of the RAD1-RAD9-HUS1 complex and RHNO1 onto chromatin, and in CHEK1 activation. May also serve as a sensor of DNA replication progression, and may be involved in homologous recombination..
Protein Sequence MSKTFLRPKVSSTKVTDWVDPSFDDFLECSGVSTITATSLGVNNSSHRRKNGPSTLESSRFPARKRGNLSSLEQIYGLENSKEYLSENEPWVDKYKPETQHELAVHKKKIEEVETWLKAQVLERQPKQGGSILLITGPPGCGKTTTLKILSKEHGIQVQEWINPVLPDFQKDDFKGMFNTESSFHMFPYQSQIAVFKEFLLRATKYNKLQMLGDDLRTDKKIILVEDLPNQFYRDSHTLHEVLRKYVRIGRCPLIFIISDSLSGDNNQRLLFPKEIQEECSISNISFNPVAPTIMMKFLNRIVTIEANKNGGKITVPDKTSLELLCQGCSGDIRSAINSLQFSSSKGENNLRPRKKGMSLKSDAVLSKSKRRKKPDRVFENQEVQAIGGKDVSLFLFRALGKILYCKRASLTELDSPRLPSHLSEYERDTLLVEPEEVVEMSHMPGDLFNLYLHQNYIDFFMEIDDIVRASEFLSFADILSGDWNTRSLLREYSTSIATRGVMHSNKARGYAHCQGGGSSFRPLHKPQWFLINKKYRENCLAAKALFPDFCLPALCLQTQLLPYLALLTIPMRNQAQISFIQDIGRLPLKRHFGRLKMEALTDREHGMIDPDSGDEAQLNGGHSAEESLGEPTQATVPETWSLPLSQNSASELPASQPQPFSAQGDMEENIIIEDYESDGT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
21UbiquitinationKVTDWVDPSFDDFLE
CCCCCCCCCHHHHHH
27.5529967540
32UbiquitinationDFLECSGVSTITATS
HHHHHCCCCEEEEEE
2.3429967540
45UbiquitinationTSLGVNNSSHRRKNG
EEECCCCCCCCCCCC
23.4729967540
54PhosphorylationHRRKNGPSTLESSRF
CCCCCCCCCHHHCCC
47.2028555341
55PhosphorylationRRKNGPSTLESSRFP
CCCCCCCCHHHCCCC
37.3617494752
55UbiquitinationRRKNGPSTLESSRFP
CCCCCCCCHHHCCCC
37.3629967540
59PhosphorylationGPSTLESSRFPARKR
CCCCHHHCCCCCHHC
28.6828555341
66MethylationSRFPARKRGNLSSLE
CCCCCHHCCCCHHHH
33.41115490083
70PhosphorylationARKRGNLSSLEQIYG
CHHCCCCHHHHHHHC
36.5623898821
71PhosphorylationRKRGNLSSLEQIYGL
HHCCCCHHHHHHHCC
38.8123186163
71UbiquitinationRKRGNLSSLEQIYGL
HHCCCCHHHHHHHCC
38.8129967540
74UbiquitinationGNLSSLEQIYGLENS
CCCHHHHHHHCCCCC
39.2233845483
81PhosphorylationQIYGLENSKEYLSEN
HHHCCCCCHHHHHCC
19.93-
82UbiquitinationIYGLENSKEYLSENE
HHCCCCCHHHHHCCC
63.0629967540
83UbiquitinationYGLENSKEYLSENEP
HCCCCCHHHHHCCCC
52.0729967540
84PhosphorylationGLENSKEYLSENEPW
CCCCCHHHHHCCCCC
21.1823312004
85UbiquitinationLENSKEYLSENEPWV
CCCCHHHHHCCCCCH
5.6229967540
86PhosphorylationENSKEYLSENEPWVD
CCCHHHHHCCCCCHH
37.1621815630
94UbiquitinationENEPWVDKYKPETQH
CCCCCHHHCCCCCHH
45.6229967540
96UbiquitinationEPWVDKYKPETQHEL
CCCHHHCCCCCHHCH
41.9629967540
107UbiquitinationQHELAVHKKKIEEVE
HHCHHHCHHHHHHHH
49.5229967540
111UbiquitinationAVHKKKIEEVETWLK
HHCHHHHHHHHHHHH
65.9429967540
118UbiquitinationEEVETWLKAQVLERQ
HHHHHHHHHHHHHHC
28.4729967540
124UbiquitinationLKAQVLERQPKQGGS
HHHHHHHHCCCCCCE
54.6729967540
141UbiquitinationLITGPPGCGKTTTLK
EEECCCCCCHHHHHH
6.6129967540
143UbiquitinationTGPPGCGKTTTLKIL
ECCCCCCHHHHHHHH
46.9329967540
152UbiquitinationTTLKILSKEHGIQVQ
HHHHHHHHHHCCCHH
50.7329967540
160UbiquitinationEHGIQVQEWINPVLP
HHCCCHHHHHCCCCC
52.0133845483
170UbiquitinationNPVLPDFQKDDFKGM
CCCCCCCCCCCCCCC
56.5029967540
171UbiquitinationPVLPDFQKDDFKGMF
CCCCCCCCCCCCCCC
60.2933845483
197UbiquitinationQSQIAVFKEFLLRAT
HHHHHHHHHHHHHHH
40.7429967540
208UbiquitinationLRATKYNKLQMLGDD
HHHHHHCCHHHCCCC
36.6929967540
210UbiquitinationATKYNKLQMLGDDLR
HHHHCCHHHCCCCCC
27.0229967540
221UbiquitinationDDLRTDKKIILVEDL
CCCCCCCEEEEEECC
37.4829967540
222UbiquitinationDLRTDKKIILVEDLP
CCCCCCEEEEEECCC
3.4729967540
249UbiquitinationVLRKYVRIGRCPLIF
HHHHHHHHCCCCEEE
2.6629967540
293PhosphorylationSFNPVAPTIMMKFLN
CCCCCCHHHHHHHHH
16.2717924679
304PhosphorylationKFLNRIVTIEANKNG
HHHHHCEEEEECCCC
15.6617924679
308UbiquitinationRIVTIEANKNGGKIT
HCEEEEECCCCCEEE
26.0729967540
319UbiquitinationGKITVPDKTSLELLC
CEEECCCCCHHHHHH
33.6629967540
335PhosphorylationGCSGDIRSAINSLQF
CCCCCHHHHHHHHHC
33.56-
335UbiquitinationGCSGDIRSAINSLQF
CCCCCHHHHHHHHHC
33.5629967540
346UbiquitinationSLQFSSSKGENNLRP
HHHCCCCCCCCCCCC
72.6729967540
359PhosphorylationRPRKKGMSLKSDAVL
CCCCCCCCCCHHHHH
41.1226074081
362PhosphorylationKKGMSLKSDAVLSKS
CCCCCCCHHHHHCHH
35.77-
367PhosphorylationLKSDAVLSKSKRRKK
CCHHHHHCHHHCCCC
28.43-
410PhosphorylationILYCKRASLTELDSP
HHHHCCCCCCCCCCC
39.6029255136
412PhosphorylationYCKRASLTELDSPRL
HHCCCCCCCCCCCCC
31.8229255136
416PhosphorylationASLTELDSPRLPSHL
CCCCCCCCCCCCHHC
25.2521815630
421UbiquitinationLDSPRLPSHLSEYER
CCCCCCCHHCHHHCC
41.4729967540
494PhosphorylationRSLLREYSTSIATRG
HHHHHHHHHHHHHHC
15.7828857561
500UbiquitinationYSTSIATRGVMHSNK
HHHHHHHHCCCCCCC
27.0429967540
579PhosphorylationMRNQAQISFIQDIGR
CCCHHHHHHHHHHCC
12.2926270265
586UbiquitinationSFIQDIGRLPLKRHF
HHHHHHCCCCHHHHH
33.2029967540
597UbiquitinationKRHFGRLKMEALTDR
HHHHCHHHHHHHHCC
33.0829967540
633PhosphorylationEESLGEPTQATVPET
HHHCCCCCCCCCCCE
26.91-
646PhosphorylationETWSLPLSQNSASEL
CEECCCCCCCCCCCC
25.9414871926
656PhosphorylationSASELPASQPQPFSA
CCCCCCCCCCCCCCC
40.2211602352
676PhosphorylationENIIIEDYESDGT--
CCEEEEECCCCCC--
12.44-
678PhosphorylationIIIEDYESDGT----
EEEEECCCCCC----
34.80-
681PhosphorylationEDYESDGT-------
EECCCCCC-------
40.19-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
633TPhosphorylationKinaseATMQ13315
PSP
646SPhosphorylationKinaseATMQ13315
Uniprot
646SPhosphorylationKinaseATRQ13535
Uniprot
656SPhosphorylationKinaseATMQ13315
Uniprot
656SPhosphorylationKinaseATRQ13535
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
646SPhosphorylation

11418864
656SPhosphorylation

11418864

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RAD17_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RFC2_HUMANRFC2physical
14605214
RFC3_HUMANRFC3physical
14605214
RFC4_HUMANRFC4physical
14605214
RFC5_HUMANRFC5physical
14605214
DPOE1_HUMANPOLEphysical
14500819
DPOE2_HUMANPOLE2physical
14500819
DPOE3_HUMANPOLE3physical
14500819
DPOE4_HUMANPOLE4physical
14500819
RAD9A_HUMANRAD9Aphysical
12578958
HUS1_HUMANHUS1physical
12578958
RAD1_HUMANRAD1physical
12578958
RAD9A_HUMANRAD9Aphysical
10884395
HUS1_HUMANHUS1physical
10884395
RAD1_HUMANRAD1physical
10884395
NH2L1_HUMANNHP2L1physical
10593953
RAD1_HUMANRAD1physical
11418864
CLSPN_HUMANCLSPNphysical
16885023
CADH1_HUMANCDH1physical
20424596
ANM6_HUMANPRMT6physical
23455924
UBP20_HUMANUSP20physical
24923443
RFC4_HUMANRFC4physical
28514442
RFC3_HUMANRFC3physical
28514442
RFC2_HUMANRFC2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RAD17_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"The human checkpoint Rad protein Rad17 is chromatin-associatedthroughout the cell cycle, localizes to DNA replication sites, andinteracts with DNA polymerase epsilon.";
Post S.M., Tomkinson A.E., Lee E.Y.-H.P.;
Nucleic Acids Res. 31:5568-5575(2003).
Cited for: FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, MUTAGENESIS OFSER-646 AND SER-656, AND INTERACTION WITH POLE.
"Phosphorylation of serines 635 and 645 of human Rad17 is cell cycleregulated and is required for G(1)/S checkpoint activation in responseto DNA damage.";
Post S.M., Weng Y.-C., Cimprich K., Chen L.B., Xu Y., Lee E.Y.-H.P.;
Proc. Natl. Acad. Sci. U.S.A. 98:13102-13107(2001).
Cited for: FUNCTION, PHOSPHORYLATION AT SER-646 AND SER-656, INTERACTION WITHRFC4, AND MUTAGENESIS OF SER-191; SER-646 AND SER-656.
"ATR/ATM-mediated phosphorylation of human Rad17 is required forgenotoxic stress responses.";
Bao S., Tibbetts R.S., Brumbaugh K.M., Fang Y., Richardson D.A.,Ali A., Chen S.M., Abraham R.T., Wang X.-F.;
Nature 411:969-974(2001).
Cited for: FUNCTION, INTERACTION WITH ATM; ATR AND RAD1, PHOSPHORYLATION ATSER-646 AND SER-656, AND MUTAGENESIS OF SER-646 AND SER-656.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-304, AND MASSSPECTROMETRY.

TOP